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 Aims: The aim of this review was to define the place of
stress echocardiography in the context of perfusion scintig-
raphy for the detection of coronary artery disease (CAD)
and the assessment of cardiac risk. Stress echocardiography
has the benefits of widespread availability, relatively low
cost, portability, absence of radiation, and the determi-
nation of the ischaemic threshold. However, the echocar-
diographic windows are variable, sometimes with poor
echogenicity, and interpretation is subjective and requires
an adequate learning period.
Methods and Results: Diagnostic and prognostic com-
parisons were focused on studies comparing stress (exercise,
dobutamine, adenosine or dipyridamole) echocardiography
and perfusion scintigraphy in the same patients. These
direct diagnostic comparisons (22 studies for a total of 1380
patients) show that stress echocardiography may be some-
what less sensitive in detecting and localizing mild CAD (in1525-2167/00/010010+10 $35.00/0particular when vasodilators are used), but is more specific
than perfusion scintigraphy. The direct prognostic com-
parisons (five studies for a total of 805 patients) show that
stress echocardiography and perfusion scintigraphy have
comparable prognostic value.
Conclusions: At this moment, stress echocardiography
already seems very competitive with perfusion scintigraphy.
In the near future, improvement in endocardial border
detection and quantitation of wall motion analysis are
expected to improve the value of stress echocardiography
still further.
(Eur J Echocardiography 2000; 1: 12–21)
 2000 The European Society of Cardiology
Key Words: Coronary artery disease; Diagnosis; Perfusion
scintigraphy; Stress echocardiography; Risk assessment.focus on studies involving performance of both echocar-
diographic and scintigraphic imaging in the same
patients for each of the most widely used stress tech-
niques: exercise, dobutamine, and the direct vasodilators
adenosine and dipyridamole. For these comparisons to
be valid, we assume that the investigators in these
studies are equally expert in either technique.*Address for correspondence: M. L. Geleijnse, Thoraxcenter, Room
BA 302, Dr Molewaterplein 40, 3015 GD Rotterdam, The
Netherlands.Methods and Statistical Analysis
A MedLine search on stress echocardiographic and
perfusion scintigraphic studies published in the major
English language journals was performed, using theIntroduction
Stress echocardiography and myocardial perfusion
scintigraphy are often used for the detection of coronary
artery disease (CAD) and the assessment of cardiac
risk [1–26]. This review attempts to define the place of
stress echocardiography in the context of perfusion
scintigraphy. As a number of variables (referral bias,
extent and severity of CAD, definition of significant
CAD, stress protocols, medications) may potentially
influence the results of either test, the comparisons will 2000 The European Society of Cardiology
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or exercise) and (echocardiography or thallium or
technetium). Studies were only included in the main
diagnostic and prognostic analysis if both stress
echocardiography and perfusion scintigraphy was per-
formed in all patients, using the same cardiac stressor.
Studies were only included in the diagnostic analysis if
these studies included patients both with and without
angiographically defined CAD, and if it was stated how
many patients with and without CAD had negative and
positive test results. Studies describing special issues
such as women and patients with left bundle branch
block (LBBB) of left ventricular hypertrophy (LVH)
were excluded from the primary diagnostic analysis.
Special issues such as these were discussed separately.
Sensitivity was defined as the number of true positive
tests divided by the total number of patients with
angiographically significant CAD. Specificity was de-
fined as the number of true negative tests divided by the
total number of patients without angiographically sig-
nificant CAD. Mean values for sensitivity and specificity
were calculated by combining the results of individual
patient data from multiple studies. Comparisons of
sensitivity and specificity were performed using the
standardized normal distribution test. Statistical
significance was defined as P<0·05.by guest on O
ctober 19, 2015
rom
 Basic Principles of Stress
Echocardiography Versus Perfusion
Scintigraphy
In the presence of a flow-limiting coronary artery sten-
osis, exercise or pharmacological stress results in a
sequence of functional events, known as the ‘ischaemic
cascade’[27]. According to this cascade, perfusion abnor-
malities (visualized at perfusion scintigraphy by rela-
tively reduced tracer uptake) due to limited coronary
flow reserve precede decreased myocardial contractility
(visualized at echocardiography by abnormal regional
systolic function).
The development of myocardial perfusion defects with
either exercise or pharmacological stress depends on the
induction of regional heterogeneity of myocardial blood
flow. Coronary blood flow to the vascular bed of a
normal artery dramatically increases during stress,
whereas perfusion through a stenosed artery may change
only minimally. Because the initial uptake of radio-
pharmaceuticals is flow-dependent within physiological
ranges[28], the relative myocardial radionuclide concen-
tration will be greater in vascular beds supplied by a
normal artery relative to that in beds perfused by an
artery with significant obstruction.
Regional malperfusion severe enough to cause meta-
bolic consequences of ischaemia can be identified by
echocardiography, based upon the response of the left
ventricle. The normal response of the left ventricle to
exercise or dobutamine stress is to increase endocardial
excursion, the speed of contraction, and the degree ofmyocardial thickening. The most important indices
pointing to the presence of myocardial ischaemia include
stress-induced deterioration of regional endocardial
excursion, and a reduction of myocardial thickening.Strengths and Limitations of Stress
EchocardiographyClinical Considerations
Several aspects of stress echocardiography are attractive
from the standpoint of clinical feasibility. In comparison
with scintigraphic cameras, echocardiography machines
are widely available at relatively low cost, are smaller in
size and are more portable. The shorter time for per-
formance and interpretation of a stress echocardiogram
is attractive in the outpatient setting. Finally, the
absence of ionizing radiation may be attractive to
the public, for some of whom nuclear tests have a bad
image.Imaging Considerations
Two-dimensional echocardiography provides the ability
to visualize the heart using a non-invasive, real-time
approach. As ischaemia may be observed on-line, appro-
priate action can be taken during the test. Documen-
tation of the ischaemic threshold can provide important
information about the severity and extent of underlying
CAD. Non-ischaemic explanations for the patient symp-
toms may be apparent from the visualization of valve
anatomy and gradients or pericardial eﬀusion. Finally,
specificity lowering (breast) attenuation artifacts at
perfusion scintigraphy are not problematic with
echocardiography. The relative weaknesses of stress
echocardiography are the sometimes poor echocardio-
graphic windows (especially in obese or lung emphysema
patients), making a correct interpretation diﬃcult or
impossible, and the visual (subjective) interpretation,
which requires an important learning curve even for
experienced echocardiographers[29–31].Diagnostic Accuracy of the Imaging
ModalitiesExercise Stress Echocardiography Versus
Perfusion Scintigraphy
Table 1 shows the sensitivity and specificity for the
detection of CAD in seven studies[1–7], directly compar-
ing exercise echocardiography and perfusion scintigra-
phy in the same 397 patients. The sensitivities of both
tests for the identification of CAD were comparable
(78% vs 83%, respectively), although there was a higher
sensitivity for perfusion scintigraphy in the setting of
single vessel CAD (78% vs 67%, respectively, P<0·05).Eur J Echocardiography, Vol. 1, issue 1, March 2000
14 M. L. Geleijnse and A. ElhendyThere was a trend towards a better specificity for stress
echocardiography (91% vs 83%, P<0·10).by guest on O
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 Dobutamine Stress Echocardiography
Versus Perfusion Scintigraphy
Also shown in Table 1 are the sensitivity and specificity
values reported in eight studies[8–15], comprising 593
patients who underwent simultaneous dobutamine
stress echocardiography and perfusion scintigraphy.
Dobutamine stress perfusion scintigraphy was the more
sensitive test: 86% vs 80% (P<0·05). Dobutamine stress
echocardiography, however, was the more specific test:
86% vs 73% (P<0·005). The finding that stress perfusion
scintigraphy is more sensitive (especially in patients with
single vessel CAD) is in line with the ischaemic cascade
theory[27], which states that perfusion abnormalities due
to limited coronary flow reserve precede wall motion
abnormalities. That the diﬀerence in sensitivity between
exercise or dobutamine stress echocardiography and
perfusion scintigraphy is, in fact, only very small might
be explained by two major factors: suboptimal induce-
ment of blood flow heterogeneity by exercise or
dobutamine[32] or inherent compensating strengths of
echocardiography over perfusion scintigraphy, including
improved spatial resolution, and the ability to categorize
wall motion independently in each segment (contrasting
with the relative blood flow comparisons used in
myocardial perfusion imaging).Vasodilator Stress Echocardiography Versus
Perfusion Scintigraphy
As seen in Table 1, pooled data from six studies[15–21]
directly comparing vasodilator (adenosine or dipyrida-
mole) stress echocardiography and perfusion scintigra-
phy in the same 390 patients show that the sensitivity
of vasodilator perfusion scintigraphy was superior to
that of vasodilator echocardiography (85% vs 66%,
P<0·0001), both for single-vessel CAD (78% vs 58%,Eur J Echocardiography, Vol. 1, issue 1, March 2000P<0·01) and multivessel CAD (95% vs 74%, P<0·0001).
These results are not surprising, since vasodilators
primarily create blood flow heterogeneity (detected
by perfusion scintigraphy and not echocardiography)
and true myocardial ischaemic (detected by echo-
cardiography) in only a limited number of patients.
Of note, not all studies[20] used optimal doses of vaso-
dilator to induce true myocardial ischaemia[33], and no
single comparative study used the new, promising
dipyridamole-atropine protocol34].The Optimal Pharmacological Stressor
The necessity of inducing myocardial ischaemia for the
development of wall motion abnormalities suggests that
dobutamine may be more eﬀective than a direct vaso-
dilator for stress echocardiography[35]. Indeed, pooled
data[36] from seven studies directly comparing (high-
dose) dobutamine vs (high-dose) dipyridamole or adeno-
sine stress echocardiography showed that dobutamine
stress echocardiography was the more sensitive test,
while specificity was comparable. In contrast, direct
vasodilators (adenosine or dipyridamole) are considered
the most eﬀective pharmacological drugs to create cor-
onary blood flow heterogeneity[32,35,37]. The most appro-
priate means of comparing pharmacological stress
echography and perfusion scintigraphy seems, therefore,
to be to use dobutamine with the former and a direct
vasodilator with the latter. Four studies have directly
compared these two stress modalities[15, 18, 38, 39]. In only
one study[15] was dipyridamole perfusion scintigraphy
more sensitive than (high-dose) dobutamine stress
echocardiography. Importantly, in all but one study{39],
dobutamine stress echocardiography tended to be more
specific for the detection of CAD.0
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Figure 1. Sensitivity (A) and specificity (B) of stress echocardiography (black bars) and perfusion scintigraphy
(white bars) for identification of disease in individual coronary arteries. LAD=left anterior descending
coronary artery; LCx=left circumflex coronary artery; RCA=right coronary artery.
(A) (B)Assessment of the Localization of CAD
In Figure 1, the sensitivities (Fig. 1A) and specificities
(Fig. 1B) of stress echocardiography and perfusion
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 scintigraphy for individual vessels are shown as reported
in eight studies (one report assessed two diﬀerent stres-
sors), for a total of 1,303 vessels (3, 6, 7, 11, 14, 15, 21).
The respective sensitivities were, respectively: 62% vs
72% (P<0·0001) for overall detection of individual
CAD; 69% vs 73% for left anterior descending coronary
disease; 43% vs 58% (P<0·005) for the left circumflex
coronary disease, and 69% vs 82% (P<0·001) for right
coronary disease. Specificities were, respectively, 90% vs
90%, 91% vs 92%, 92% vs 96%, and 88% vs 81%. For
both stress echocardiography and perfusion scintigra-
phy, the sensitivity for detection of left circumflex
coronary disease was (independent of the stressor) sig-
nificantly less compared to detection of CAD in other
coronary arteries. In addition to variation in coronary
anatomy (with a small circumflex territory in some
patients), perfusion scintigraphy suﬀers from a less
reliable assessment of the posterior regions of the heart
due to problems of photon attenuation, and echocardi-
ography suﬀers from problems with resolution of the
lateral wall endocardium because of the parallel orien-
tation of this wall and the ultrasound beam. Overall
diﬀerences in sensitivity for detection of individual vessel
CAD between stress cardiography and perfusion scintig-
raphy were mainly caused by the included dipyridamole
studies[15,21]. When these studies were excluded from the
analysis, overall sensitivity for detection of individual
vessel, CAD was, respectively for stress echocardiogra-
phy and perfusion scintigraphy, 69% vs 72%, and overall
specificity was 90% for both imaging modalities.stress echocardiography), imperfect assignment of
myocardial regions to coronary arteries, collateral cir-
culations, anatomically significant but functionally
non-significant lesions, and (for perfusion scintigraphy)
diﬀuse hypoperfusion.Special Subgroupsber 19, 2015Left Bundle Branch Block
In LBBB patients, exercise perfusion scintigraphic
studies often suﬀer from false positive perfusion defects
in the interventricular septum in the absence of left
anterior descending coronary stenosis[41]. Several
mechanisms have been proposed to explain these per-
fusion defects. In LBBB patients, septal contraction
occurs at the very end of systole. The regional myocar-
dial compressive eﬀect may restrict coronary blood flow
during early diastole, when most perfusion normally
occurs[42]. As the heart rate increases and diastole short-
ens, the relative septal hypoperfusion may become even
more apparent. Alternatively, with markedly delayed
septal contraction, the myocardium in this region en-
counters a decreased afterload to that of other left
ventricular segments. This may result in a relative reduc-
tion in coronary septal blood flow as a result of coronary
autoregulatory mechanisms[43]. Because of the suspected
major role of heart rate increase in the development of
septal defects, vasodilator (dipyridamole, adenosine)
perfusion scintigraphy, which causes only a moderate
increase in heart rate, is advocated as the stress test of
choice[44]. Some promising reports on the value of stress
echocardiography in LBBB patients have been pub-
lished[45,46]. In particular, in patients with preserved
interventricular septal contraction (despite LBBB)
dobutamine stress echocardiography may be a very
accurate test to detect CAD in the left anterior descend-
ing coronary[46]. However, currently there are no studies
directly comparing stress echocardiography with vaso-
dilator perfusion scintigraphy.Hypertension and/or Left Ventricular
Hypertrophy
Hypertension is a major risk factor for CAD, and a
frequent finding in patients undergoing stress testing.
Several reports have suggested that the specificity of
perfusion scintigraphy in patients with hypertension
and/or LVH to detect CAD is suboptimal[47–49]. Per-
fusion defects despite the absence of obstructive epi-
cardial CAD may be caused by a relative reduction in
the microvascular bed size and a reduction in resistance
vessels diameter secondary to vascular hypertrophy[50].
Although severely impaired perfusion may be expected
to influence stress echocardiographic results also, several
stress echocardiographic studies have shown excellent
specificity values in patients with hypertension and/orAssessment of the Extent of CAD
An important goal of stress testing is the identification
of patients with multivessel CAD, who could benefit
from revascularization from a prognostic point of
view[40]. Patients with multivessel CAD can be diﬀeren-
tiated from patients with single vessel CAD by detection
of wall motion or perfusion abnormalities in two or
more coronary territories. The relative ability of stress
echocardiography and perfusion scintigraphy to predict
the extent of CAD has been investigated in four studies
(one report assessed two diﬀerent stressors) for a total of
220 patients[7,11,15]. The mean reported sensitivity for
stress echocardiography (50%, range 14–70%) did not
diﬀer significantly from that reported for perfusion
scintigraphy (58%, range 48–77%). However, analogous
to the prior section, in one study[15] the sensitivity of
dipyridamole echocardiography for multivessel CAD
was clearly less than that of dipyridamole perfusion
scintigraphy (14% vs 57%). The mean reported specifi-
city for stress echocardiography (97%, range 90%–100%)
was comparable to that reported for perfusion scintig-
raphy (95%, range 92%–100%). The relative underesti-
mation of multivessel CAD by both imaging modalities
can be explained by the premature cessation of stress
because of the development of limiting ischaemia
(angina, ST-segment deviation, or new wall motion
abnormalities in one region as a test end-point duringEur J Echocardiography, Vol. 1, issue 1, March 2000
18 M. L. Geleijnse and A. ElhendyLVH[51–53], comparable to values for patients without
hypertension, studied in the same study[54]. Further-
more, the presence of LVH consistently did not aﬀect
the diagnostic accuracy of stress echocardiography in
patients with hypertension[55–57]. Direct comparative
studies with perfusion scintigraphy were mainly per-
formed with dobutamine stress echocardiography[9,53,56].
In retrospective studies, variable results were reported
concerning the value of this latter stress modality rela-
tive to dobutamine stress scintigraphy[9,56]. In a large,
prospective study, both dobutamine and dipyridamole
stress echocardiography were more specific than exercise
perfusion scintigraphy for the detection of CAD in
patients with a history of hypertension[53].by guest on O
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 Women
The diagnosis of CAD in women may be troublesome,
because they have (certainly until the seventh decade of
life) a relatively low pre-test probability of CAD and a
lower exercise capacity[58]. Perfusion scintigraphy may
suﬀer from additional problems, such as anterolateral
breast attenuation artifacts in rest or during stress in case
of breast movement[59], and the relatively small size
of the female heart, given that the spatial resolution of
perfusion scintigraphy is approximately 1 cm[60]. Several
stress echocardiographic studies have shown excellent
sensitivity and specificity values in women[61–63], com-
parable to values for men, studied in the same study[63].
Comparative studies with perfusion scintigraphy
were only performed for dobutamine stress echo-
cardiography[64–66]. In the studies using a high-dose
dobutamine-atropine protocol, stress echocardiography
was more accurate than dobutamine[65] and more specific
than exercise/dipyridamole[64] perfusion scintigraphy.Prognostic Accuracy of the Imaging
Modalities
Although numerous studies have described the prog-
nostic value of stress echocardiography[67], only five
prognostic studies[22–26] have directly compared the pre-
dictive value of this stress modality relative to perfusion
scintigraphy. As seen in Table 2, one study focused on
patients after acute myocardial infarction[22], two studies
focused on patients with known or suspected stable
CAD[23,24], and another two studies[25,26] focused on
patients assessed before undergoing major surgery,
describing the prediction of perioperative events. In
none of these studies was a significant diﬀerence found
between stress echocardiography and perfusion scintig-
raphy, as measured by the risk ratio of a positive test
over a negative test for the occurrence of cardiac events,
although in the preoperative era perfusion scintigraphy
tended to perform somewhat better. In both studies in
patients with known or suspected stable CAD[23,24], a
positive echocardiographic or scintigraphic study notEur J Echocardiography, Vol. 1, issue 1, March 2000only increased subsequent cardiac risk in absolute terms,
but the extent of wall motion abnormalities was at least
as discriminative as the extent of perfusion abnormali-
ties to further stratify patients into intermediate and
high-risk subsets. Most importantly, patients with a
normal stress echocardiogram or perfusion scintigram
had a comparable annual hard (cardiac death or non-
fatal myocardial infarction) event rate of less than 1%.
Thus, both stress echocardiography and stress perfusion
scintigraphy may identify a group of patients at low risk
for future cardiac events in whom no further (more
invasive) tests are required.Conclusions and Recommendations
This review has concentrated on direct comparisons of
stress echocardiography and perfusion scintigraphy for
the diagnosis of CAD and the assessment of cardiac risk.
As described, stress echocardiography has some relative
strengths and limitations For the moment stress echocar-
diography (in particular when vasodilators are used)
seems somewhat less sensitive to detecting and localizing
(mild) CAD, but seems the more specific test. These
findings may partly be explained by the relative low
stressor dose used in some studies[8,20], since it is well
known that stress echocardiography is more vulnerable
to submaximal stress[33,68,69]. However, it should also be
noted that many scintigraphic studies were not per-
formed with the newest technetium-99m SPECT tech-
nology. For prognostic purposes, more related to severe
forms of CAD, stress echocardiography and perfusion
scintigraphy seem to have comparable strength. At this
moment we recommend the following guidelines for the
use of the two imaging modalities (disregarding costs and
assuming equal available expertise for both modalities).
Perfusion scintigraphy is more useful in:
v patients with a poor echocardiographic window
(obese, airway disease);
v patients with a high pre-test probability of CAD;
v patients requiring vasodilator stress;
v patients with LBBB (in combination with a
direct vasodilator);
v detection of (anatomically defined) mild CAD.
Echocardiography is more useful in:
v patients in whom safety is a major concern;
v assessment of the functional significance of a
known stenosis;
v patients with a low pre-test probability of CAD;
v patients with a suspicion of significant valvular,
myocardial or pericardial disease.
Echocardiography may be more useful in:
v patients with hypertension and/or left ventricular
hypertrophy;
v women.
Detection of CAD: Stress Echocardiography vs. Perfusion Scintigraphy 19In the near future, many technical improvements
are expected to improve the value of stress echo-
cardiography further. In particular, changes in stress
protocols, such as the addition of atropine to dob-
utamine[70] or dipyridamole[34], improvement in endo-
cardial border detection with second harmonic
imaging[71] and contrast echocardiography[72], and quan-
titation of wall motion analysis to provide objective data
with colour kinesis[73] or tissue Doppler imaging[74] are
expected to improve the value of stress echocardiogra-
phy still further.by guest on O
ctober 19, 2015
D
ow
nloaded from
 References
[1] Wann LS, Faris JV, Childress RH, Dillon JC, Weyman AE,
Feigenbaum H. Exercise cross-sectional echocardiography in
ischemic heart disease. Circulation 1979; 60: 1300–1308.
[2] Maurer G, Nanda NC. Two dimensional echocardiographic
evaluation of exercise-induced left and right ventricular asyn-
ergy: correlation with thallium scanning. Am J Cardiol 1981;
48: 720–727.
[3] Pozzoli MMA, Fioretti PM, Salustri A, Reijs AE, Roelandt
JRTC. Exercise echocardiography and technetium-99m MIBI
single-photon emission computed tomography in the detec-
tion of coronary artery disease. Am J Cardiol 1991; 67:
350–355.
[4] Galanti G, Sciagra` R, Comeglio M et al. Diagnostic accuracy
of peak exercise echocardiography in coronary artery disease:
Comparison with thallium-201 myocardial scintigraphy. Am
Heart J 1991; 122: 1609–1616.
[5] Quin˜ones MA, Verani MS, Haichin RM, Mahmarian JJ,
Suarez J, Zoghbi WA. Exercise echocardiography versus
Thallium-201 single-photon emission computed tomography
in evaluation of coronary artery disease. Analysis of 292
patients. Circulation 1992; 85: 1026–1031.
[6] Salustri A, Pozzoli MMA, Hermans W et al. Relation between
exercise echocardiography and perfusion single-photon emis-
sion computed tomography in patients with single-vessel
coronary artery disease. Am Heart J 1992; 124: 75–83.
[7] Hecht HS, Debord L, Shaw R, Chin H, Dunlap R, Ryan C,
Myler RK. Supine bicycle stress echocardiography versus
tomographic thallium-201 exercise imaging for the detection
of coronary artery disease. J Am Soc Echocardiogr 1993; 6:
177–185.
[8] Gu¨nalp B, Dokumaci B, Uyan C et al. Value of dobutamine
Technetium-99m-Sestamibi SPECT and echocardiography in
the detection of coronary artery disease compared with
coronary angiography. J Nucl Med 1993; 34: 889–894.
[9] Marwick T, D’Hondt A, Baudhuin T, Willemart B, Wijns W,
Detry JM, Melin J. Optimal use of dobutamine stress for the
detection and evaluation of coronary artery disease: combi-
nation with echocardiography or scintigraphy, or both. J Am
Coll Cardiol 1993; 22: 159–167.
[10] Forster T, McNeill AJ, Salustri A, Reijs AE, El-Said ES,
Roelandt JRTC, Fioretti PM. Simultaneous dobutamine
stress echocardiography and 99m-technetium isonitrile single
photon emission computed tomography in patients with
suspected coronary artery disease. J Am Coll Cardiol 1993; 21:
1591–1596.
[11] Senior R, Sridhara BS, Anagnostou E, Handler C, Raftery
EB, Lahiri A. Synergistic value of simultaneous stress
dobutamine sestamibi single-photon emission computerized
tomography and echocardiography in the detection of cor-
onary artery disease. Am Heart J 1994; 128: 713–718.
[12] Di Bello V, Bellina CR, Gori E et al. Incremental diagnostic
value of dobutamine stress echocardiography and dobutamine
scintigraphy (technetium 99m-labeled sestamibi single-photonemission computed tomography) for assessment of presence
and extent of coronary artery disease. J Nucl Cardiol 1996; 3:
212–220.
[13] Kisacik HL, O} zdemir K, Altinyay E et al. Comparison of
exercise stress testing with simultaneous dobutamine stress
echocardiography and technetium-99M isonitrile single-
photon emission computerized tomography for the diagnosis
of coronary artery disease. Eur Heart J 1996; 17: 113–119.
[14] Huang PJ, Ho YL, Wu CC et al. Simultaneous dobutamine
stress echocardiography and thallium perfusion imaging for
the detection of coronary artery disease. Cardiology 1997; 88:
556–562.
[15] Santoro GM, Sciagra` R, Buonamici P et al. Head-to-head
comparison of exercise stress testing, pharmacologic stress
echocardiography, and perfusion tomography as first-line
examination for chest pain in patients without a history of
coronary artery disease. J Nucl Cardiol 1998; 5: 19–27.
[16] Nguyen T, Heo J, Ogilby JD, Iskandrian AS. Single photon
emission computed tomography with thallium-201 during
adenosine-induced coronary hyperemie: correlation with cor-
onary arteriography, exercise thallium imaging and two-
dimensional echocardiography. J Am Coll Cardiol 1990; 16:
1375–1383.
[17] Amanullah AM, Bevegard S, Lindvall K, Aasat M. Assess-
ment of left ventricular wall motion in angina pectoris by two
dimensional echocardiography and myocardial perfusion by
technetium-99m sestamibi tomography during adenosine-
induced coronary vasodilation and comparison with coronary
angiography. Am J Cardiol 1993; 72: 983–989.
[18] Marwick T, Willemart B, D’Hondt AM et al. Selection of the
optimal nonexercise stress for the evaluation of ischemic
regional myocardial dysfunction and malperfusion. Compari-
son of dobutamine and adenosine using echocardiography
and 99m Tc-MIBI single photon emission computed tom-
ography. Circulation 1993; 87: 345–354.
[19] Ferrara N, Bonaduce D, Leosco D et al. Two-dimensional
echocardiographic evaluation of ventricular asynergy induced
by dipyridamole: correlation with thallium scanning. Clin
Cardiol 1986; 9: 437–442.
[20] Perin EC, Moore W, Blume M, Hernandez G, Dhekne R,
DeCastro M. Comparison of dipyridamole echocardiography
with dipyridamole thallium scintigraphy for the diagnosis of
myocardial ischemia. Clin Nucl Med 1991; 16: 417–420.
[21] Parodi G, Picano E, Marcassa C et al. High dose dipyrida-
mole myocardial imaging: simultaneous scintigraphy and two-
dimensional echocardiography in the detection and evaluation
of coronary artery disease. Coron Art Dis 1999; 10: 177–184.
[22] Van Daele M, McNeill AJ, Fioretti PM et al. Prognostic value
of dipyridamole sestamibi single-photon emission computed
tomography and dipyridamole stress echocardiography for
new cardiac events after an uncomplicated myocardial infarc-
tion. J Am Soc Echocardiogr 1994; 7: 370–380.
[23] Geleijnse ML, Elhendy A, Cornel JH et al. Cardiac imaging
for risk stratification with dobutamine-atropine stress testing
in patients with chest pain. Echocardiography, perfusion
scintigraphy, or both? Circulation 1997; 96: 137–147.
[24] Olmos LI, Dakik H, Gordon R et al. Long-term prognostic
value of exercise echocardiography compared with exercise
201T1, ECG, and clinical variables in patients evaluated for
coronary artery disease. Circulation 1998; 98: 2679–2686.
[25] Van Damme H, Pie´rard L, Gillain D, Benoit TH, Rigo P,
Limet R. Cardiac risk assessment before vascular surgery: a
prospective study comparing clinical evaluation, dobutamine
stress echocardiography, and dobutamine Tc-99m sestamibi
tomoscintigraphy. Cardiovasc Surg 1997; 5: 54–64.
[26] Pasquet A, D’Hondt AM, Verhelst R, Vanoverschelde JL,
Melin J, Marwick TH. Comparison of dipyridamole stress
echocardiography and perfusion scintigraphy for cardiac risk
stratification in vascular surgery patients. Am J Cardiol 1998;
82: 1468–1474.
[27] Nesto RW, Kowalchuck GJ. The ischemic cascade: Tem-
poral sequence of hemodynamic, electrocardiographic andEur J Echocardiography, Vol. 1, issue 1, March 2000
20 M. L. Geleijnse and A. Elhendy
by guest on O
ctober 19, 2015
D
ow
nloaded from
 symptomatic expressions of ischemia. Am J Cardiol 1987; 57:
23C–27C.
[28] Leppo JA, Meerdink DA. Comparison of the myocardial
uptake of a technetium-labeled isonitrile analogue and thal-
lium. Circ Res 1989; 64: 632–639.
[29] Picano E, Lattanzi F, Orlandini A, Marini C, L’Abbate A.
Stress echocardiography and the human factor: the impor-
tance of being expert. J Am Coll Cardiol 1991; 24: 928–933.
[30] Varga A, Picano E, Dodi C, Barbieri L, Pratali L, Gaddi O.
Madness and method in stress echo reading. Eur Heart J 1999;
20: 1271–1275.
[31] Hoﬀmann R, Lethen H, Marwick T et al. Analysis of inter-
institutional observer agreement in the interpretation of dob-
utamine stress echocardiogram. J Am Coll Cardiol 1996; 27:
330–336.
[32] Pennel DJ, Ell PJ. Whole-body imaging of thallium-201 after
six diﬀerent stress regimens. J Nucl Med 1994; 35: 425–428.
[33] Casanova R, Petroncini A, Guidotti PL, Capacci PF, Jacopi
F, Fabbri M, Maresta A. Dose and test for dipyridamole
infusion and cardiac imaging early after uncomplicated acute
myocardial infarction. Am J Cardiol 1992; 70: 1402–1406.
[34] Picano E, Pingitore A, Conti U et al. Enhanced sensitivity for
detection of coronary artery disease by addition of atropine to
dipyridamole echocardiography. Eur Heart J 1993; 14: 1216–
1222.
[35] Fung AY, Gallagher KP, Buda AJ. The physiologic basis of
dobutamine as compared with dipyridamole stress inter-
ventions in the assessment of critical coronary stenosis. Circu-
lation 1987; 76: 943–951.
[36] Geleijnse ML, Marwick TH, Boersma E, Deckers JW, Melin
JA, Fioretti PM. Optimal pharmacological stress testing
for the diagnosis of coronary artery disease: a probabilistic
approach. Eur Heart J 1995; 16 (Suppl M): 3–10.
[37] Lee J, Chae SC, Lee K, Heo J, Iskandrian AS. Biokinetics of
thallium-201 in normal subjects: comparison between adeno-
sine, dipyridamole, dobutamine and exercise. J Nucl Med
1994; 35: 535–541.
[38] Smart SC, Bhatia N, Stoiber T. Dobutamine-atropine stress
echocardiography and dipyridamole sestamibi scintigraphy
for the detection of coronary artery disease: limitations and
concordance. J Am Coll Cardiol (in press).
[39] Ho FM, Huang PJ, Liau CS, Lee FK, Chieng PU, Su CT, Lee
YT. Dobutamine stress echocardiography compared with
dipyridamole thallium-201 single-photon emission computed
tomography in detecting coronary artery disease. Eur Heart J
1995; 16: 570–575.
[40] Caliﬀ RM, Harrell FE Jr, Lee KL et al. The evolution of
medical and surgical therapy for coronary artery disease: a
15-year perspective. JAMA 1989; 67: 302–309.
[41] Hirzel HO, Senn M, Nuessch K, Bettner C, Pfeiﬀer A, Hess
OM, Krayenbuehl HP. Thallium-201 scintigraphy in
complete left bundle branch block. Am J Cardiol 1984; 53:
764–769.
[42] Ono S, Nohara R, Kambara H, Okuda K, Kawai C. Regional
myocardial perfusion and glucose metabolism in experimental
left bundle branch block. Circulation 1995; 85: 1125–1131.
[43] Olsson RA, Bunger R. Metabolic control of coronary flow.
Prog Cardiovasc Dis 1987; 29: 369–387.
[44] O’Keefe J, Bateman TM, Barnhart CS. Adenosine thallium-
201 is superior to exercise thallium-201 for detecting coronary
artery disease in patients with left bundle branch block. J Am
Coll Cardiol 1993; 21: 1332–1338.
[45] Mairesse GH, Marwick TH, Arnese M et al. Improved
identification of coronary artery disease in patients with
left bundle branch block by use of dobutamine stress echo-
cardiography and comparison with myocardial perfusion
tomography. Am J Cardiol 1995; 76: 321–325.
[46] Geleijnse ML, Vigna C, Kasprzak JD et al. Usefulness and
limitations of dobutamine-atropine stress echocardiography
for the diagnosis of coronary artery disease in patients with
left bundle branch block. A multicenter study. Eur Heart J
2000; (in press).Eur J Echocardiography, Vol. 1, issue 1, March 2000[47] Schulman DS, Francis CK, Black HR, Wackers FJT.
Thallium-201 stress imaging in hypertensive patients. Hyper-
tension 1987; 10: 16–21.
[48] DePuey EG, Guertler-Krawczynska E, Perkins JV, Robbins
WL, Whelchel JD, Clements SD. Alterations in myocardial
thallium-201 distribution in patients with chronic systemic
hypertension undergoing 201 single-photon emission com-
puted tomography. Am J Cardiol 1988; 62: 234–238.
[49] Houghton JL, Frank MJ, Car AA, Von Dohlen TW, Prisant
LM. Relations among impaired coronary flow reserve, left
ventricular hypertrophy and thallium perfusion defects in
hypertensive patients without obstructive coronary artery
disease. J Am Coll Cardiol 1990; 15: 43–51.
[50] Tomanek RJ. Response of the coronary vasculature to myo-
cardial hypertrophy. J Am Coll Cardiol 1990; 15: 528–533.
[51] Picano E, Lucarini AR, Lattanzi F, Distante A, Legge VD,
Salvetti A, L’Abbate A. Dipyridamole echocardiography in
essential hypertension patients with chest pain. Hypertension
1988; 12: 238–243.
[52] Marwick TH, Torelli J, Harjai K, Haluska B, Pashkow F,
Stewart WJ, Thomas JD. Influence of left ventricular hyper-
trophy on detection of coronary artery disease using exercise
echocardiography. J Am Coll Cardiol 1995; 26: 1180–1186.
[53] Fragasso G, Lu C, Dabrowski P, Pagnotta P, Sheiban I,
Chierchia SL. Comparison of stress/rest myocardial perfusion
tomography, dipyridamole and dobutamine stress echocardi-
ography for the detection of coronary disease in hypertensive
patients with chest pain and positive exercise test. J Am Coll
Cardiol 1999; 34: 441–447.
[54] Elhendy A, Van Domburg RT, Roelandt JRTC, Geleijnse
ML, Mohsen Ibrahim M, Fioretti PM. Safety and feasibility
of dobutamine-atropine stress testing in hypertensive patients.
Hypertension 1997; 29: 1232–1239.
[55] Senior R, Basu S, Handler C, Raftery EB, Lahiri A. Diagnos-
tic accuracy of dobutamine stress echocardiography for detec-
tion of coronary heart disease in hypertensive patients. Eur
Heart J 1996; 17: 289–295.
[56] Elhendy A, Geleijnse ML, Van Domburg RT et al. Compari-
son of dobutamine stress echocardiography and technetium-
99m sestamibi single-photon emission tomography for the
diagnosis of coronary artery disease in hypertensive patients
with and without left ventricular hypertrophy. Eur J Nucl Med
1998; 25: 69–78.
[57] Ho YL, Wu CC, Lin LC et al. Assessment of the coronary
artery disease and systolic dysfunction in hypertensive patients
with dobutamine-atropine stress echocardiography: eﬀect of
the left ventricular hypertrophy. Cardiology 1998; 89: 52–58.
[58] Chaitman BR, Bourassa MG, Davis K et al. Angiographic
prevalence of high risk coronary artery disease in patients
subsets (CASS). Circulation 1981; 64: 360–367.
[59] Gordon DePuey G, Garcia EV. Optimal specificity of
thallium-201 SPECT through recognition of imaging artifacts.
J Nucl Med 1989; 30: 441–449.
[60] Hansen CL, Crabbe D, Rubin S. Lower diagnostic accuracy
of thallium-201 SPECT myocardial perfusion imaging in
women: an eﬀect of smaller chamber size. J Am Coll Cardiol
1996; 28: 1214–1219.
[61] Masini M, Picano E, Lattanzi F, Distante A, L’Abbate A.
High dose dipyridamole-echocardiography test in women:
correlation with exercise-echocardiography test and coronary
arteriography. J Am Coll Cardiol 1988; 12: 682–685.
[62] Marwick TH, Anderson T, Williams MJ et al. Exercise
echocardiography is an accurate and cost-eﬃcient technique
for detection of coronary artery disease in women. J Am Coll
Cardiol 1995; 26: 335–341.
[63] Elhendy A, Geleijnse ML, Van Domburg RT et al. Gender
diﬀerences in the accuracy of dobutamine stress echocardiog-
raphy for the diagnosis of coronary artery disease. Am J
Cardio. 1997; 80: 1414–1418.
[64] Takeuchi M, Sonoda S, Miura Y, Kuroiwa A. Comparative
diagnostic value of dobutamine stress echocardiography
and stress thallium-201 single-photon emission computed
Detection of CAD: Stress Echocardiography vs. Perfusion Scintigraphy 21tomography for detecting coronary artery disease in women.
Coron Art Dis 1996; 7: 831–835.
[65] Elhendy A, Van Domburg RT, Bax JJ, Nierop PR, Geleignse
ML, Ibrahim MM, Roelandt JRTC. Noninvasive diagnosis
of coronary artery stenosis in women with limited exercise
capacity. Comparison of dobutamine stress echocardiography
and 99mTc sestamibi single-photon emission CT. Chest 1998;
114: 1097–1104.
[66] Ho YL, Wu CC, Huang PJ et al. Assessment of coronary
artery disease in women by dobutamine stress echocardiogra-
phy: comparison with stress thallium-201 single-photon emis-
sion computed tomography and exercise electrocardiography.
Am Heart J 1998; 135: 655–662.
[67] Marwick TH. Current status of stress echocardiography for
diagnosis and prognostic assessment of coronary artery
disease. Coron Art Dis 1998; 9: 411–426.
[68] Marwick TH, D’Hondt AM, Mairesse GH, Baudhuin T,
Wijns W, Detry JM, Melin JA. Comparative ability of dob-
utamine and exercise stress in inducing myocardial ischemia in
active patients. Br Heart J 1994; 72: 31–38.
[69] Hutchinson SJ, Shen A, Soldo S, Hla A, Kawanishi DT,
Chandraratna AN. Transesophageal assessment of coronaryflow velocity reserve during ‘regular’ and ‘high’-dose dipyri-
damole stress testing. Am J Cardiol 1996; 77: 1164–1168.
[70] McNeill AJ, Fioretti PM, El-Said EM, Salustri A, Forster R,
Roelandt JRTC. Enhanced sensitivity for detection of cor-
onary artery disease by addition of atropine to dobutamine
stress echocardiography. Am J Cardiol 1992; 70: 41–46.
[71] Spencer KY, Bednarz J, Rafter PG, Korcarz C, Lang RM.
Use of harmonic imaging without echocardiographic contrast
to improve two-dimensional image quality. Am J Cardiol
1998; 82: 794–799.
[72] Porter TR, Xie F, Kricsfeld A, Chiou A, Dabestani A.
Improved endocardial border resolution during dobutamine
stress echocardiography with intravenous sonicated dextrose
albumin. J Am Coll Cardiol 1994; 23: 1440–1443.
[73] Koch R, Lang RM, Garcia MJ et al. Objective evaluation of
regional left ventricular wall motion during dobutamine stress
echocardiographic studies using segmental analysis of color
kinesis images. J Am Coll Cardiol 1999; 34: 409–419.
[74] Sutherland GR, Stewart MJ, Groundstroem KWE et al.
Color Doppler myocardial imaging: A new technique for the
assessment of myocardial function. J Am Soc Echocardiogr
1994; 7: 441–458.Eur J Echocardiography, Vol. 1, issue 1, March 2000
by guest on O
ctober 19, 2015
D
ow
nloaded from
 
